Similarly, CRP was higher in patients with severe COVID-19 compared to all other groups (p < 0·001, ANCOVA), while lymphocyte counts were lower in severe, as opposed to mild disease (p < 0·01, ANCOVA) (Table 1). The gene discussed is CRP; the disease is COVID-19.